The DOI matches its Crossref record; 123 of the 124 references it cites were found in a registry or an index.
Review of WADA Prohibited Substances: Limited Evidence for Performance-Enhancing Effects
Open accessAbstract
The World Anti-Doping Agency is responsible for maintaining a Prohibited List that describes the use of substances and methods that are prohibited for athletes. The list currently contains 23 substance classes, and an important reason for the existence of this list is to prevent unfair competition due to pharmacologically enhanced performance. The aim of this review was to give an overview of the available evidence for performance enhancement of these substance classes. We searched the scientific literature through PubMed for studies and reviews evaluating the effects of substance classes on performance. Findings from double-blind, randomized controlled trials were considered as evidence for (the absence of) effects if they were performed in trained subjects measuring relevant performance outcomes. Only 5 of 23 substance classes show evidence of having the ability to enhance actual sports performance, i.e. anabolic agents, β2-agonists, stimulants, glucocorticoids and β-blockers. One additional class, growth hormone, has similar evidence but only in untrained subjects. The observed effects all relate to strength or sprint performance (and accuracy for β-blockers); there are no studies showing positive effects on reliable markers of endurance performance. For 11 classes, no well-designed studies are available, and, for the remaining six classes, there is evidence of an absence of a positive effect. In conclusion, for the majority of substance classes, no convincing evidence for performance enhancement is available, while, for the remaining classes, the evidence is based on a total of only 266 subjects from 11 studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“For instance, according to Heuberger et al., only five of 23 substance classes on the WADA prohibited list have robust evidence of actually having the ability to enhance sports performance in athletes (3).”
From The Inclusion in WADA Prohibited List Is Not Always Supported by Scientific Evidence: A Narrative Review (2021) · cites this paper as [3]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,813
The Levels of Evidence and Their Role in Evidence-Based Medicine
Burns, P. B., Rohrich, R. J., & Chung, K. C. (2011) · Plastic and Reconstructive Surgery · doi:10.1097/prs.0b013e318219c171 · Cited by 2,155
The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men
Bhasin, S., Storer, T. W., Berman, N., Callegari, C., Clevenger, B., Phillips, J., Bunnell, T. J., Tricker, R., Shirazi, A., & Casaburi, R. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607043350101 · Cited by 1,659
Endurance exercise performance: the physiology of champions
Joyner, M. J., & Coyle, E. F. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2007.143834 · Cited by 1,307
AMPK and PPARδ Agonists Are Exercise Mimetics
Narkar, V. A., Downes, M., Yu, R. T., Embler, E., Wang, Y.-X., Banayo, E., Mihaylova, M. M., Nelson, M. C., Zou, Y., Juguilon, H., et al. (2008) · Cell · doi:10.1016/j.cell.2008.06.051 · Cited by 1,222
Effects of Androgenic-Anabolic Steroids in Athletes
Hartgens, F., & Kuipers, H. (2004) · Sports Medicine · doi:10.2165/00007256-200434080-00003 · Cited by 873
Steed, D. L., & Study Group *, T. D. U. (1995) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(95)70245-8 · Cited by 612
Gupta, N., & Wish, J. B. (2017) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2016.12.011 · Cited by 444
Influence of diuretic-induced dehydration on competitive running performance
ARMSTRONG, L. E., COSTILL, D. L., & FINK, W. J. (1985) · Medicine & Science in Sports & Exercise · doi:10.1249/00005768-198508000-00009 · Cited by 406
Amann, M., Proctor, L. T., Sebranek, J. J., Pegelow, D. F., & Dempsey, J. A. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2008.163303 · Cited by 393
Research works printed but not linked: 1
- The World Anti-Doping Agency. Standard prohibited list 2018. Montreal: World Anti-Doping Agency; 2018.
Cited by
The molecular athlete: exercise physiology from mechanisms to medals
Furrer, R., Hawley, J. A., & Handschin, C. (2023) · Physiological Reviews · doi:10.1152/physrev.00017.2022 · Cited by 217
Lampert, R., Chung, E. H., Ackerman, M. J., Arroyo, A. R., Darden, D., Deo, R., Dolan, J., Etheridge, S. P., Gray, B. R., Harmon, K. G., et al. (2024) · Heart Rhythm · doi:10.1016/j.hrthm.2024.05.018 · Cited by 167
Varillas‐Delgado, D., Coso, J. D., Gutiérrez‐Hellín, J., Aguilar‐Navarro, M., Muñoz, A., Maestro, A., & Morencos, E. (2022) · European Journal of Applied Physiology · doi:10.1007/s00421-022-04945-z · Cited by 179
Annual banned‐substance review: analytical approaches in human sports drug testing
Thevis, M., Kuuranne, T., Geyer, H., & Schänzer, W. (2011) · Drug Testing and Analysis · doi:10.1002/dta.245 · Cited by 131
Mechanisms and Clinical Applications of Glucocorticoid Steroids in Muscular Dystrophy
Quattrocelli, M., Zelikovich, A. S., Salamone, I. M., Fischer, J. A., & McNally, E. M. (2020) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-200556 · Cited by 87
Metadata
- Authors
- Heuberger, J. A. A. C., & Cohen, A. F.
- Affiliations
- Centre for Human Drug Research (NL)
- Leiden University Medical Center (NL)
- Corresponding author
- Heuberger, Jules A. A. C.
- Venue
- Sports Medicine
- Published
- 2018-11-08
- Volume
- 49
- Issue
- 4
- Pages
- 525-539
- ISSN
- 0112-1642 (ISSN-L)
- 1179-2035
- PMC
- PMC6422964
- OpenAlex
- W2899886633
- Cited by
- 108
- References
- 124
- Citations by year
- 2026: 9 · 2025: 8 · 2024: 29 · 2023: 15 · 2022: 17 · 2021: 10 · 2020: 8 · 2019: 10
- FWCI
- 2.49
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- Locations
- Sports Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Sociology and Political Science › Doping in Sports
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Pharmacological Effects and Assays
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Sports Performance and Training
- Keywords
- prohibited substances, World Anti-Doping Agency, performance-enhancing drugs, anabolic agents, beta-adrenergic agonists, stimulants, glucocorticoids, beta-blockers, growth hormone, athletic performance, endurance performance
- MeSH terms
- Adrenergic beta-Antagonists, Central Nervous System Stimulants, Doping in Sports, Humans, Steroids, Randomized Controlled Trials as Topic, Human Growth Hormone, Intercellular Signaling Peptides and Proteins, Peptide Hormones, Anabolic Agents, Athletic Performance, Evidence-Based Practice, Performance-Enhancing Substances
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Review of WADA Prohibited Substances: Limited Evidence for Performance-Enhancing Effects. https://app.cochat.ai/papers/10.1007/s40279-018-1014-1
- The paper
- Heuberger, J. A. A. C., & Cohen, A. F. (2019). Review of WADA Prohibited Substances: Limited Evidence for Performance-Enhancing Effects. Sports Medicine. https://doi.org/10.1007/s40279-018-1014-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.